Direct epitope study using human IgE mAbs against peanut allergens - 05/05/25
Doi : 10.1016/j.jaci.2025.02.021
Hirohisa Saito, MD, PhD a, b, ⁎ 
, Masato Tamari, MD, PhD a, Tatsuki Fukuie, MD, PhD c, Kenji Matsumoto, MD, PhD a, Hideaki Morita, MD, PhD a, c
, Masato Tamari, MD, PhD a, Tatsuki Fukuie, MD, PhD c, Kenji Matsumoto, MD, PhD a, Hideaki Morita, MD, PhD a, c a Department of Allergy and Clinical Immunology, National Research Institute for Child Health & Development, Tokyo, Japan
b Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan
c Allergy Center, National Center for Child Health and Development, Tokyo, Japan
∗Corresponding author: Hirohisa Saito, MD, PhD, Department of Allergy and Clinical Immunology, National Research Institute for Child Health & Development, 2-10-1, Okura, Setagaya-ku, Tokyo 157-8535, Japan.Department of Allergy and Clinical ImmunologyNational Research Institute for Child Health & Development2-10-1OkuraSetagaya-kuTokyo157-8535Japan
Key words : Ara h 2, immunogenomics, single-cell RNA sequencing, peanut allergy
Le texte complet de cet article est disponible en PDF.
© 2025
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 155 - N° 5
P. 1483-1485 - mai 2025 Retour au numéro
Article précédent
- Is dupilumab use in atopic dermatitis associated with cutaneous T-cell lymphoma?
- Peck Y. Ong
- The 2025 AAAAI Foundation Faculty Development awardees
- Zuhair K. Ballas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?